Percentage of earn out payments during each year as a part of business combination.

No definition available.

Name:	nhwk_BusinessAcquisitionAnnualizedEarnOutPaymentsPercentage
Namespace Prefix:	nhwk_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Earn out payments period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessAcquisitionEarnOutPaymentsPeriod
Namespace Prefix:	nhwk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Frequency occurrence of periodic (monthly, quarterly, annual) earn payment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessAcquisitionFrequencyOfPeriodicEarnOutPayment
Namespace Prefix:	nhwk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Period when earn payment occurs, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessAcquisitionPeriodOfOccurrenceOfEarnOutPayment
Namespace Prefix:	nhwk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The additional earn out liabilities calculated as a percentage of gross sale price under business combination.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationAdditionalEarnOutLiabilitiesAsPercentageOfGrossSalePrice
Namespace Prefix:	nhwk_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents number of pre-filled vials for which the additional earn out liability of the estimated gross sales price is considered for calculation.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationAdditionalEarnOutLiabilitiesOfGrossSalePriceForNumberOfPreFilledVials
Namespace Prefix:	nhwk_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Fair value of amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationConsiderationTransferredFairValue
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of deferred contingent payment under business combination.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationDeferredContingentPayment
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The discount rate used in the preliminary valuation of deferred consideration arising from business combination.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationDiscountRateForDeferredConsideration
Namespace Prefix:	nhwk_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The discount rate used in the preliminary valuation of earn out liabilities arising from business combination.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationDiscountRateForEarnOutLiabilities
Namespace Prefix:	nhwk_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The period for which the goodwill arising from business combination will be deductible for tax purposes.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationGoodwillTaxDeductiblePeriod
Namespace Prefix:	nhwk_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The preliminary estimated fair value of the contingent and deferred consideration liabilities related to the receivable consideration, contract deferred consideration, earn out and additional earn out payments arising from business combination.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationPreliminaryEstimatedFairValueOfContingentAndDeferredConsiderationLiabilities
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of receivable consideration arising from business combination.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationReceivableConsideration
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Business Combination Receivable Consideration Balance

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationReceivableConsiderationBalance
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of receivable consideration paid during the period.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationReceivableConsiderationPaid
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of contract receivables recognized as of the acquisition date.

+ References

No definition available.

+ Details

Name:	nhwk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractReceivables
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479907/805-20-50-5

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479328/805-10-50-2

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481372/852-10-55-10

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482548/350-20-55-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482598/350-20-45-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The parent entity's interest in net assets of the subsidiary, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_OwnershipAxis=nhwk_PelicanTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=nhwk_PelicanTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=us-gaap_StockholdersEquityTotalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=nhwk_ElusysTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Acquisitions - Narrative (Details)		1 Months Ended	3 Months Ended
Acquisitions - Narrative (Details)	Apr. 18, 2022 USD ($) item	Apr. 30, 2022 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2023	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Oct. 31, 2018	Sep. 30, 2018	Dec. 31, 2017
Pelican Therapeutics, Inc.
Acquisitions
Ownership interest in subsidiary				85.00%		85.00%	85.00%	80.00%
Pelican Therapeutics, Inc.
Acquisitions
Percentage of voting interests acquired in acquisition									80.00%
Cash consideration			$ 200,000
Pelican Therapeutics, Inc. \| Stockholders
Acquisitions
Cash consideration			$ 300,000
Elusys Therapeutics
Acquisitions
Earn out payments period	12 years
Percentage of earn out payments	10.00%	10.00%
Frequency of periodic earn out payment	1 year	1 year
Period of occurrence of earn payment	9 years	9 years
Receivable consideration	$ 22,318,685
Consideration paid		$ 20,800,000
Holding back related to future fulfillment cost		$ 1,500,000
Contract receivables	24,526,232
Fair value of the purchase consideration	42,900,000
Cash consideration	3,000,000
Deferred cash consideration	2,000,000
Fair value of contingent and deferred consideration liabilities	$ 37,900,000
Discount rate for deferred consideration	24.00%
Discount rate for earn out liabilities	14.00%
Preliminary value of Additional Earn Out liability as percentage	80.00%
Goodwill	$ 3,873,080				$ 3,900,000	$ 3,301,959
Goodwill deductible for tax purposes	15 years
Number of pre-filled vials of ANTHIM \| item	1,500